A prospective observational study to evaluate the effect of the dose rate on infectious/non-infectious pneumonitis and pulmonary toxicities in patients who receive total body irradiation (TBI) prior to allogeneic hematopoietic stem cell transplantations

A prospective observational study to evaluate the effect of the dose rate on infectious/non-infectious pneumonitis and pulmonary toxicities in patients who receive total body irradiation (TBI) prior to allogeneic hematopoietic stem cell transplantations - The effect of dose rate in TBI on pulmonary toxicities after allo-HSCT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036441

Enrollment

Registered

2019-04-08

Start date

2019-04-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AML/MDS, ALL, Malignant lymphoma, AA

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Any patient who receives total body radiation as a conditioning therapy at Dept. Radiation Oncology and Image-Applied therapy, Kyoto University Hospital, followed by a allogeneic hematopoietic stem cell tranpslantation at Dept. Hematology and Oncology, Kyoto University Hospital.

Exclusion criteria

Exclusion criteria: Patients who disagree with this study

Design outcomes

Primary

Measure	Time frame
Incidence of infectious/non-infectious pneumonitis and pulmonary toxicities within 1 year after transplantation	—

Countries

Japan

Contacts

Public ContactJunya Kanda

Graduate School of Medicine, Kyoto University Dept. Hematology and Oncology

jkanda16@kuhp.kyoto-u.ac.jp075-751-3111

Outcome results